Yanfang Yang1, Liying Yuan1, Hui Xiong2

  • 1College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials of Ministry of Education, Nankai University, Tianjin, 300071, China.

概括

化合物丹申滴剂 (CDDP) 通过抑制Wnt/β-catenin通路并激活Sirt1.1,有效地减少小鼠和细胞的血管化. 这种传统中医药在改善心血管疾病风险因素方面发挥了新的治疗作用.